AAIPHarma Services and Cambridge Major Laboratories

AAIPHarma Services and Cambridge Major Laboratories have announced the resignation of their join CEO, Patrick Walsh. Susan Nestegard will replace Walsh as interim CEO.

The two companies are owned by American Capital Ltd, which began their merger in October 2013, creating an 800-employee firm with seven sites in the US and Europe. AAIPharma Services is a provider of pharmaceutical analytical testing, product development and manufacturing services, while Cambridge performs contract active pharmaceutical ingredient (API) development and manufacturing.

Walsh joined AAIPharma in 2010 as CEO and oversaw the unification of the two companies. “Now that the initial foundation, leadership team and process initiatives have been identified, it is time for me to step down,” stated Patrick Walsh. “Over the last 6 months, I was asked to shepherd the two organizations through the first phase of the integration process.”